Wellth Inc.
7
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
83.3%
-3.2% vs industry average
0%
0 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication
Role: collaborator
The Use of Mobile Health Technology and Behavioral Economics to Encourage Adherence in Adolescents
Role: collaborator
Habitual Hypertension Medication Adherence in Arizona
Role: collaborator
Evaluation of an Incentive-based Intervention to Improve 90-day Adherence in PAP-Naive Patients
Role: collaborator
Telehealth Intervention for Improved Blood Pressure Control With Targeted Incentives
Role: lead
A Behavioral Economics-Based Telehealth Intervention to Improve Post-MI Medication Adherence
Role: lead
Mobile App With Patient Financial Incentives for Adherence to Heart Failure Medications & Daily Self-Weighing
Role: lead
All 7 trials loaded